Inhibition of diabetes in NOD mice by idiotypic induction of SLE

Journal of Autoimmunity

Volumn 13, Issue 1, 1999, Pages 49-55

  Krause, I ^b   Tomer, Y ^b   Elias, D ^a   Blank, M ^b   Gilburd, B ^b   Cohen, I R ^a   Shoenfeld, Y ^b  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b NONE

Author keywords

Autoantibodies; Diabetes; Idiotypes; NOD; SLE

Indexed keywords

GLUCOSE; HEAT SHOCK PROTEIN 60; IDIOTYPIC ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MIV 7; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; IMMUNIZATION; IMMUNOGLOBULIN DEPOSITION; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; LEUKOPENIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; SUBCUTANEOUS DRUG ADMINISTRATION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA;

EID: 0032803292     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1999.0292     Document Type: Conference Paper

References (36)

1. Baxter A.G., Horsfall A.C., Healey D., Ozegbe P., Day S., Williams D.G., Cooke A. Mycobacteria precipitate an SLE-like syndrome in diabetes-prone NOD mice. Immunology. 83:1994;227-231.
2. Horsfall A.C., Howson R., Silveira P., Williams D.G., Baxter A.G. Characterization and specificity of B-cell responses in lupus induced by Mycobacterium bovis in NOD/Lt mice. Immunology. 95:1998;8-17.
3. Gazda L.S., Baxter A.G., Lafferty K.J. Regulation of autoimmune diabetes: characteristics of non- islet-antigen specific therapies. Immunol. Cell. Biol. 74:1996;401-407.
4. Weiss P., Shoenfeld Y. Shifts in autoimmune diseases: the kaleidoscope of autoimmunity. Isr. J. Med. Sci. 27:1991;215-217.
5. Lorber M., Gershwin M.E., Shoenfeld Y. The coexistence of systemic lupus erythematosus with other autoimmune diseases: the kaleidoscope of autoimmunity. Arthritis Rheum. 24:1994;105-113.
6. Shoenfeld Y., Lorber M., Yucel T., Yazici H. Primary antiphospholipid syndrome emerging following thymectomy for myasthenia gravis: additional evidence for the kaleidoscope of autoimmunity. Lupus. 6:1997;474-476.
7. Mevorach D., Perrot S., Buchanan N.M., Khamashta M., Laoussadi S., Hughes G.R., Menkes C.J. Appearance of systemic lupus erythematosus after thymectomy: four case reports and review of the literature. Lupus. 4:1995;33-37.
8. Rodrigue S., Laborde H., Catoggio P.M. Systemic lupus erythematosus and thyrotoxicosis: a hitherto little recognised association. Ann. Rheum. Dis. 48:1989;424-427.
9. Kleiner-Baumgarten A., Schlaeffer F., Keynan A. Multiple autoimmune manifestations in a splenectomized subject with HLA-B8. Arch. Intern. Med. 143:1983;1987-1989.
10. Blank M., Krause I., Ben Bassat M., Shoenfeld Y. Induction of experimental anti-phospholipid syndrome associated with SLE following immunization with human monoclonal pathogenic anti-DNA idiotype. J. Autoimmun. 5:1992;495-509.
11. Mendlovic S., Brocke S., Shoenfeld Y., Ben Bassat M., Meshorer A., Bakimer R., Mozes E. Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype. Proc. Natl. Acad. Sci. USA. 85:1988;2260-2264.
12. Blank M., Krup M., Mendlovic S., Fricke H., Mozes E., Talal N., Coates A.R., Shoenfeld Y. Theimportance of the pathogenic 16/6 idiotype in the induction of SLE in naive mice. Scand. J. Immunol. 31:1990;45-52.
13. Shoenfeld Y. Idiotypic induction of autoimmunity: a new aspect of the idiotypic network. FASEB J. 8:1994;1296-1301.
14. Tincani A., Balestrieri G., Allegri F., Cattaneo R., Fornasieri A., Li M., Sinico A., D'Amico G. Induction of experimental SLE in naive mice by immunization with human polyclonal anti-DNA antibody carrying the 16/6 idiotype. Clin. Exp. Rheumatol. 11:1993;129-134.
15. Jerne N.K. Towards a network theory of the immune system. Ann. Immunol. Paris. 125:1974;373-389.
16. Jerne N.K., Roland J., Cazenave P.A. Recurrent idiotopes and internal images. EMBO J. 1:1982;243-247.
17. Sadelain M.W., Qin H.Y., Lauzon J., Singh B. Prevention of type I diabetes in NOD mice by adjuvant immunotherapy. Diabetes. 39:1990;583-589.
18. Elias D., Cohen I.R. Treatment of autoimmune diabetes and insulitis in NOD mice with heat shock protein 60 peptide p277. Diabetes. 44:1995;1132-1138.
19. Elias D., Cohen I.R. Peptide therapy for diabetes in NOD mice. Lancet. 343:1994;704-706.
20. Elias D., Meilin A., Ablamunits V., Birk O.S., Carmi P., Konen Waisman S., Cohen I.R. Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various beta-cell antigens. Diabetes. 46:1997;758-764.
21. Burnet F.M. The clonal selection theory of acquired immunity. 1959;Cambridge University Press, Cambridge.
22. Burnet F.M. Self and non-self. 1969;Cambridge University Press, Cambridge.
23. Gottlieb P.A., Eisenbarth G.S. Mouse and man: multiple genes and multiple autoantigens in the aetiology of type I DM and related autoimmune disorders. J. Autoimmun. 9:1996;277-281.
24. Roep B.O. T-cell responses to autoantigens in IDDM. The search for the Holy Grail. Diabetes. 45:1996;1147-1156.
25. Mills J.A. Systemic lupus erythematosus. N. Engl. J. Med. 330:1994;1871-1879.
26. Kaufman D.L., Clare-Salzler M., Tian J., Forsthuber T., Ting G.S., Robinson P., Atkinson M.A., Sercarz E.E., Tobin A.J., Lehmann P.V. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature. 366:1993;69-72.
27. Tisch R., Yang X.D., Singer S.M., Liblau R.S., Fugger L., McDevitt H.O. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature. 366:1993;72-75.
28. Cohen I.R. The cognitive paradigm and the immunological homunculus. Immunol. Today. 13:1992;490-494.
29. Villarreal G.M., Drenkard C., Villa A.R., Slor H., Shafrir S., Bakimer R., Shoenfeld Y., Alarcon-Segovia D. Prevalence of 13 autoantibodies and of the 16/6 and related pathogenic idiotypes in 465 patients with systemic lupus erythematosus and their relationship with disease activity. Lupus. 6:1997;425-435.
30. Shoenfeld Y., Isenberg D.A. Mycobacteria and autoimmunity. Immunol. Today. 9:1988;178-182.
31. Sela O., El-Roeiy A., Isenberg D.A., Kennedy R.C., Colaco C.B., Pinkhas J., Shoenfeld Y. A common anti-DNA idiotype in sera of patients with active pulmonary tuberculosis. Arthritis Rheum. 30:1987;50-56.
32. Shoenfeld Y., Vilner Y., Coates A.R., Rauch J., Lavie G., Shaul D., Pinkhas J. Monoclonal anti-tuberculosis antibodies react with DNA, and monoclonal anti-DNA autoantibodies react with Mycobacterium tuberculosis. Clin. Fxp. Immunol. 66:1986;255-261.
33. Bowman M.A., Leiter E.H., Atkinson M.A. Prevention of diabetes in the NOD mouse: implications for therapeutic intervention in human disease. Immunol. Today. 15:1994;115-120.
34. Elias D., Cohen I.R. The hsp60 peptide p277 arrests the autoimmune diabetes induced by the toxin streptozotocin. Diabetes. 45:1996;1168-1172.
35. Elias D., Prigozin H., Polak N., Rapoport M., Lohse A.W., Cohen I.R. Autoimmune diabetes induced by the beta-cell toxin STZ. Immunity to the 60-kDa heat shock protein and to insulin. Diabetes. 43:1994;992-998.
36. Cohen I.R. Treatment of autoimmune disease: to activate or to deactivate? Chem. Immunol. 60:1995;150-160.